participation in research projects

Health Innovation Ventures currently participates in two European funded research programmes (Horizon2020) and one Intterreg consortium project. There is extensive expertise present at HIV regarding the writing, obtaining and executing large scale subsidies. The granting authorities are often the European Commission (Horizon2020), National Governments (Eurostars) and  Euregional platforms (Interreg).

If you are interested in reaching out to Health Innovation Ventures - ore one of its affiliated companies - please contact us.

current projects

Health Innovation Ventures currently participates in:

PREDICT: A new era in personalised medicine. Radiomics as decision support tool for diagnostics and  theragnostics in oncology.

IMMUNOSABR: Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer.

These projects have received funding from the European Union’s Horizon 2020 research and innovation programme.